Mar 18, 2020
Serious Lack of Donors of Organs is Helping to Increasing Popularity of Heart Pump Devices Market; Valuation to Rise Up to US$4.3 Bn by 2027, Notes TMR
Mar 03, 2020
The Future of the Global Cardiac Assist Devices Industry, 2025 - Abbott and Medtronic are the Key Vendors
Feb 25, 2020
The Global Cardiac Assist Devices Market to Reach Revenues of Over $2 Billion During the Period 2020 -2025 - Market Research by Arizton
Jan 07, 2020
FDA Approves Less Invasive Surgical Approach for Abbott's Heart Pump to Help Patients Avoid Open Heart Surgery
Nov 07, 2019
Triple-Gene Announces Completion of Enrollment and Dosing in Phase 1 Trial of INXN-4001, First Multigenic Investigational Therapeutic Candidate for Treatment of Heart Failure
Jul 22, 2019
Nanowear Announces Clinical Launch of NanoSENSE, a Heart Failure Management and Alert Diagnostic Validation Study
Nov 13, 2018
Growing Adoption of Electrophysiology Ablation Devices Dominating Unmet Technology Industry
Oct 19, 2018
Abbott's HeartMate 3 Heart Pump Now FDA Approved for Advanced Heart Failure Patients Not Eligible for a Heart Transplant
May 21, 2018
Heart Pump Device (Extracorporeal and Implantable Pump) Market 2018 - Global Forecast to 2022
May 17, 2018
Heart Pump Device Market by Product, Type, Therapy - Global Forecast to 2022
May 10, 2018
Heart Pump Devices Market Worth 3.98 Billion USD by 2022
Apr 12, 2018
Ventricular Assist Devices Market Expected to Reach $1,773 Million, Globally, by 2023 - Allied Market Research
Mar 11, 2018
New Long-Term Data Show Improved Survival and Lower Rates of Stroke and Pump Thrombosis for Abbott's HeartMate 3 Heart Pump
Nov 03, 2017
Global Circulatory Support Devices Marketto 2021 - Market to Grow at a CAGR of 11.1%
Aug 28, 2017
Abbott Introduces HeartMate 3 Left Ventricular Assist System - the Latest Milestone In Therapy For Advanced Heart Failure Patients